JPIAMR is pleased to welcome the nine new Scientific Advisory Board (SAB) members that have been appointed by the JPIAMR Management Board for the period 2022-2024. The new members are:
- Ana Alastruey, Instituto de Salud Carlos III, Spain
- Uga Dumpis, Pauls Stradiņš University Hospital, Latvia
- Sabiha Essack, University of KwaZulu Natal, South Africa
- Luca Guardabassi, University of Copenhagen, Denmark
- Christian Giske, Karolinska Institute, Sweden
- Geetanjali Kapoor, Center for Disease Dynamics, Economics & Policy, India
- Joakim Larsson, University of Gothenburg, Sweden
- Nilton Lincopan, Universidade de São Paulo, Brazil
- Kornelia Smalla, Julius Kühn Institute, Germany
Read more about the JPIAMR Scientific Advisory Board
Welcome to our new website!
The new JPIAMR website has been launched! It has a new design and new structure with the aim to improve user accessibility.
The site’s content is now partly re-structured and we have created clear entries on the start page to the most sought after content. All research calls have their own pages with links to the projects and networks awarded funding within each call. The Projcets section contains a possibility to filter projects by call or by JPIAMR Priority topic. Upcoming JPIAMR events such as workshops and webinars are now clearly visible on the start page, and below this you will find entries to some of our recources such as our AMR KNowledge Hub and our media library.
We hope that you will enjoy our new website. If you are having trouble finding something or wish to give us feedback, please contact us at email@example.com.
JPIAMR is launching an international call for projects under the umbrella of the JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION.
The call “One Health interventions to prevent or reduce the development and transmission of AMR”, with financial support from the European Commission, includes 30 funding organisations from 21 JPIAMR member countries. The total estimated call budget is 24.9 million Euro.
The call advocates for a One Health approach to understand the impact of interventions on the development and transmission of antibiotic resistance and to design, implement, evaluate, and compare interventions that will have a true impact on preventing or reducing the development and transmission of antibiotic resistance in and between the different One Health settings (human, animal, environment).
The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in Low- and middle-income countries (LMICs).
For more information please visit the call webpage: utveckling.jpiamr.eu/interventions-and-transmission-call-2021
More information on the upcoming call “One Health interventions to prevent or reduce the development and transmission of AMR”, including a partner search tool is now available.
Pre-announcement: One Health interventions to prevent or reduce the development and transmission of AMR
Early 2021 an international call for projects will be launched under the umbrella of the JPIAMR and within the framework of the ERA-NET JPIAMR-ACTION. The call, that will receive financial support from the European Commission, will include 30 funding organisations from 21 JPIAMR member countries. Proposals will be evaluated in a two-step procedure (pre-proposals/full proposals). The call will be launched on January 14th, 2021 and applicants will have up to March 16th, 2021, 12:00 (CET) to submit their pre-proposals.
A match-making partner search tool has been created for applicants, to facilitate networking and the creation of consortia.
Visit the call webpage for updated information on the context and topic of the call and to access the partner search tool: utveckling.jpiamr.eu/interventions-and-transmission-call-2021
Seven networks have been recommended for funding within the JPIAMR 10th transnational call: “JPIAMR Network Plus 2020”.
Seven networks including 146 partners from 35 countries have been recommended for funding within the JPIAMR 10th transnational call: “JPIAMR Network Plus 2020”. The total funding amount is approx. 737.000 €.
The call was launched in February 2020 and supported by research-funding organisations from eight JPIAMR member countries.
The intent of the call was to support networks to design and implement ways to support AMR research considering at least one of the six strategic areas of the JPIAMR Strategic Research and Innovation Agenda (SRIA): Therapeutics, Diagnostics, Surveillance, Transmission, Environment and Interventions. Networks should develop and implement activities focusing on AMR within the domains of Human health, Animal health and the Environment. The Networks were encouraged to bridge multiple One Health areas as needed and to consider the incorporation of their activities within the JPIAMR-Virtual Research Institute (JPIAMR-VRI).
Read more and see list of all networks recommended for funding.
Networks working on AMR in the context of viral-bacterial co-infections, including those working with Covid-19, are eligible to apply for the call.
The intent of the call “JPIAMR Network Plus 2020” is to support networks to design and implement ways to support AMR research considering at least one of the six strategic areas of the JPIAMR Strategic Research and Innovation Agenda: Therapeutics, Diagnostics, Surveillance, Transmission, Environment and Interventions. Networks should develop and implement activities focusing on AMR within the domains of Human health, Animal health and the Environment. Networks working on AMR in the context of viral-bacterial co-infections, including those working with Covid-19, are eligible to apply for the call.
The tenth JPIAMR joint call for transnational networks is in partnership with seven JPIAMR member countries; Canada, France, Italy, Latvia, Norway, Spain, and Sweden. The deadline for submission of applications is May 28th, 17.00 CET. Read more here.
Antimicrobial resistance (AMR) has become one of the major global health and development challenges of the 21st century. The threat of AMR is particularly high in resource-limited and high-risk settings. This is linked to weak human and animal health systems; diverse means of food production, processing and consumption; food safety and food security; water, hygiene and sanitation challenges; and the global movement of people and goods.
In response to these challenges, the JPIAMR will launch a joint transnational call for proposals for innovative research projects on new or improved diagnostics and surveillance strategies, tools, technologies and methods. These research projects should address diagnosis of AMR infections in clinical and veterinary settings, or the emergence, surveillance, and/or detection of AMR in humans, animals and the environment. This Call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, e.g. in LMIC settings in Asia and Africa. Projects are encouraged to use a One Health approach where relevant. The projected call budget is approx. 20 million Euro.
Scope of the call
Projects should aim to either:
- Develop strategies, tools, technologies, and methods for the detection, monitoring, profiling and/or surveillance of antimicrobial resistance and dynamics leading to resistance.
- Study ways to facilitate and implement the uptake and use of existing strategies, tools, technologies, and/or methods for the detection, monitoring, profiling and surveillance of antimicrobial resistance and dynamics leading to resistance.
List of participating countries is provisional.
Consortia of eligible scientists from participating JPIAMR member countries and eligible countries in Africa and Asia may apply to this call. Full eligibility criteria will be included in the Call launch. Participating JPIAMR member countries include Canada, Czech Republic, Finland, France, Germany, Israel, Italy, Latvia, Norway, Poland, Romania, Spain and Sweden. Consortia must include a minimum of three and a maximum of six project partners from at least three eligible countries.
The Netherlands has the intention of joining the call but no funding is guaranteed yet. Updates on the progress will be shared.
- November 2018 – Pre-announcement of the call
- December 2018 – Publication of the call
- February 2019 – Submission deadline for pre-proposal
- April 2019 – Full proposal invitations sent to project coordinators
- June 2019 – Submission deadline for full proposals
- October/November – Final funding decision announced
- December 2019/ Early 2020 – Project start
Download as pdf
On November 5 and 6, the G7 Ministerial Meeting on Health took place in Milan, Italy. On the agenda for the second day was antimicrobial resistance (AMR). The discussions focused on crucial topics of global health. The aim of the meeting was among else to coordinate global and concrete actions. In that context, participating Health Ministers expressed that they welcome the establishment of the Global AMR R&D Hub and call to ensure it becomes an effective platform to align and increase global investment in much needed R&D based on WHO recommendations, e.g. the Priority Pathogen List (PPL). They expressed support for the collaboration of the Global AMR R&D Hub with existing international networks and initiatives like the Interagency Coordination Group on AMR, the Global Antibiotic Research & Development Partnership (GARDP), CARB-X and the Joint Programming Initiative on AMR (JPIAMR). G7 Health Ministers expressed support for the development of evidence-based strategies, tools and interventions to fight AMR, and sustain research related to the Strategic Objectives of the WHO Global Action Plan. As well as to promote R&D for new antimicrobials, alternative therapies, vaccines and rapid-point-of care diagnostics, in particular for WHO-defined priority pathogens and tuberculosis.
JPIAMR welcomes the G7 Health Ministers focus on global coordination, supported R&D areas and the many dimensions of Antibiotic Resistance, the impacts are real now. The actions of JPIAMRs 26 member nations concerted efforts to meet human needs- and scientific results are tangible today. JPIAMR has merged the shared Strategic Research Agenda with a One Health approach. A crucial component and strategy since antimicrobial resistance do not adhere to any boundaries. In 2018 JPIAMR launches it´s 6th call: Innovation against antibiotic resistant bacteria – New targets, compounds and tools. This as a direct response to the WHO Priority Pathogens List (PPL). Coordinating participating nations resources for funding research that targets the 12 groups of bacteria and drug-resistant tuberculosis listed by WHO.
JPIAMR also welcome the initiative of the Global AMR R&D Hub, working side by side to ensure that innovation is in focus and not duplication. Seeing that a diverse range of research and resources can match and harness AMR as the multidimensional global threat it is.
Working together makes the difference we need – to harness AMR in time.